This website is not intended for adverse event reporting. To report an adverse event for FYCOMPA, FIRDAPSE, or AGAMREE, call 1 (844) 347-3277.
Adverse events may also be reported to Catalyst Pharmaceuticals by calling 1 (305) 420-3200 and the FDA by calling 1 (800) FDA-1088 or by visiting www.fda.gov/medwatch.
If you are not a US-based HCP and have questions about FYCOMPA, please visit https://www.eisai.com/index.html. If you are not a US-based HCP and have questions about AGAMREE, please visit https://www.santhera.com.
Uses and important safety information for FYCOMPA
WARNING: SERIOUS PSYCHIATRIC AND BEHAVIORAL REACTIONS
See full prescribing information for complete boxed warning
- Serious or life-threatening psychiatric and behavioral adverse reactions including aggression, hostility, irritability, anger, and homicidal ideation and threats have been reported in patients taking FYCOMPA (5.1)
- Monitor patients for these reactions as well as for changes in mood, behavior, or personality that are not typical for the patient, particularly during the titration period and at higher doses (5.1)
- FYCOMPA should be reduced if these symptoms occur and should be discontinued immediately if symptoms are severe or are worsening (5.1)
To access the full prescribing information for FYCOMPA, please click here.
To access the full prescribing information for FIRDAPSE, please click here.
To access the full prescribing information for AGAMREE, please click here.
